What is Oncolytics Biotech, Inc. Common Shares's Market Cap?

Oncolytics Biotech, Inc. Common Shares's Market Cap is $104.3M, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's Enterprise Value?

Oncolytics Biotech, Inc. Common Shares's Enterprise Value is $100.2M, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's EV / EBITDA?

Oncolytics Biotech, Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's Net Income (TTM)?

Oncolytics Biotech, Inc. Common Shares's Net Income (TTM) is -$37.5M, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's EBITDA?

Oncolytics Biotech, Inc. Common Shares's EBITDA is -$37.6M, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's Diluted EPS (TTM)?

Oncolytics Biotech, Inc. Common Shares's Diluted EPS (TTM) is -0.29, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's Net Debt?

Oncolytics Biotech, Inc. Common Shares's Net Debt is -$4.1M, based on as-reported figures from SEC (XBRL) filings.

Oncolytics Biotech, Inc. Common Shares (ONCY) Financial Statements

Oncolytics Biotech, Inc. Common Shares

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SDGSF3

XNAS · usd

0.82▼ 0.03 (-2.98%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.84

Day's Range0.83 – 0.85

52-Week Range0.73 – 1.51

Volume462.1K

Avg Volume691.6K

Share Statistics

Shares Outstanding

Employees29

ExchangeXNAS

Listed2001-10-05

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Oncolytics Biotech, Inc. Common Shares (ONCY)

What is Oncolytics Biotech, Inc. Common Shares's Market Cap?: Oncolytics Biotech, Inc. Common Shares's Market Cap is $104.3M, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's Enterprise Value?: Oncolytics Biotech, Inc. Common Shares's Enterprise Value is $100.2M, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's EV / EBITDA?: Oncolytics Biotech, Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's Net Income (TTM)?: Oncolytics Biotech, Inc. Common Shares's Net Income (TTM) is -$37.5M, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's EBITDA?: Oncolytics Biotech, Inc. Common Shares's EBITDA is -$37.6M, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's Diluted EPS (TTM)?: Oncolytics Biotech, Inc. Common Shares's Diluted EPS (TTM) is -0.29, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's Net Debt?: Oncolytics Biotech, Inc. Common Shares's Net Debt is -$4.1M, based on as-reported figures from SEC (XBRL) filings.